THIRUVANANTHAPURAM: Taking a significant step forward in haemophilia care, the health department is set to establish a ...

A promising new treatment for Lyme disease, a condition transmitted through tick bites, is in development and aims to offer ...

Researchers evaluated whether interferon-α nasal spray reduces the incidence of COVID-19 or other respiratory viral infections among adults with cancer.

Hospitalizations due to RSV cases in infants are reduced by up to 43% following the introduction of new maternal vaccines.

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

Leqembi ® Iqlik™, a subcutaneous (SC) formulation of lecanemab, is now available as a maintenance dosing regimen for the treatment of Alzheimer disease in patients with mild cognitive impairment or ...

Sanofi and Galderma are competitors in the pharmaceutical space. Galderma’s Nemluvio is a monoclonal antibody approved by the FDA to treat adults with PN, and to treat moderate-to-severe eczema in ...

The FDA has granted Fast Track designation to Bristol Myers Squibb’s anti-MTBR-tau antibody (BMS-986446) for the treatment of early Alzheimer disease.

Jade Biosciences (JBIO) unveiled JADE201, its investigational half-life extended, afucosylated monoclonal antibody targeting the B-cell activating ...

JADE201 builds on clinical proof-of-concept for BAFF-R targeting, adding half-life extension technology to provide extended receptor occupancy ...

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the "Agreement") with QIMR Berghofer for ...